Results 151 to 160 of about 524,692 (354)
Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks
British Journal of Clinical Pharmacology, EarlyView.The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou +2 more
wiley +1 more source
Decision Making Algorithms: Product Liability and the Challenges of AI
Bruno Deffains, Claude-Denys Fluet
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Regulation of Food Supplements and Pharmacists' Responsibility in Professional Practice: A Review. [PDF]
Pharmacy (Basel)Niculaș CI +5 more
europepmc +1 more source
Constricting Products Liability: Reforms in Theory and Procedure
, 2003 Frank J. Vandall
openalex +1 more source
British Educational Research Journal, EarlyView.Abstract Drawing upon interview research across two academic departments as part of the early stages of a ‘decolonise the curriculum’ initiative at a Southern UK university, this study highlights a growing gulf between policy and practice in efforts to address systemic racial inequalities in UK universities. A reliance upon precarious labour, a culture
Triona Fitton +4 more
wiley +1 more source
Diverging regulatory DNA in adaptive medical AI: US agility and EU accountability in lifecycle governance. [PDF]
Front Med (Lausanne)Lee JH +6 more
europepmc +1 more source
Pharmaceutical Product Liability and the Propensity to Patent: An Empirical Firm-Level Investigation
, 2020 Mitja Kovač, Salvini Datta, Rok Spruk
openalex +1 more source